Clinical Trial Update: Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer) [Phase 2]

View source ↗

Summary

A Phase 2 trial called Newton (NEW Dosing Maintenance Therapy Ovarian Cancer) sponsored by the Mario Negri Institute has been terminated. The study evaluated ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: TERMINATED